Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors), Bcl-xl inhibitors(Apoptosis regulator Bcl-X inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | US | 23 Aug 2021 | |
Acute Myeloid Leukemia | Phase 1 | US | 23 Aug 2021 | |
Blast Phase Chronic Granulocytic Leukemia | Phase 1 | US | 23 Aug 2021 | |
Chronic lymphocytic leukaemia refractory | Phase 1 | US | 23 Aug 2021 | |
Chronic Myelomonocytic Leukemia | Phase 1 | US | 23 Aug 2021 | |
Mycosis Fungoides | Phase 1 | US | 23 Aug 2021 | |
Recurrent Hematologic Malignancy | Phase 1 | US | 23 Aug 2021 | |
Refractory Hematologic Malignancy | Phase 1 | US | 23 Aug 2021 | |
Rhabdoid Tumor of the CNS | Phase 1 | US | 23 Aug 2021 | |
Timothy Syndrome | Phase 1 | US | 23 Aug 2021 |